Enhanced liver fibrosis score is stable after withdrawal in patients with heavy alcohol consumption: A pilot study.
alcohol withdrawal
alcohol‐related liver disease
enhanced liver fibrosis
liver fibrosis
Journal
Alcohol, clinical & experimental research
ISSN: 2993-7175
Titre abrégé: Alcohol Clin Exp Res (Hoboken)
Pays: United States
ID NLM: 9918609780906676
Informations de publication
Date de publication:
15 Apr 2024
15 Apr 2024
Historique:
revised:
24
02
2024
received:
11
11
2023
accepted:
08
03
2024
medline:
16
4
2024
pubmed:
16
4
2024
entrez:
15
4
2024
Statut:
aheadofprint
Résumé
Enhanced liver fibrosis (ELF) score is an accurate, noninvasive test for assessing the severity of liver fibrosis in chronic liver disease, including alcohol-related liver disease. However, whether the ELF score changes during alcohol withdrawal is unknown. This pilot study assessed changes in the ELF score during withdrawal in patients with a history of excessive alcohol intake. In this prospective study, ELF was performed on day 0 (D0, at the beginning of hospitalization), at day 7 (D7, on discharge from hospital), and at follow-up visits on days 30 (D30) and 90 (D90). Transient elastography (TE) was also assessed on days 4 (D4) and D30. The study included 35 patients (71% male) with a mean alcohol intake of 139 g/day. On D30 and D90, 8 and 13 patients had resumed alcohol consumption (mean intake of 90 and 80 g/day, respectively). In patients who remained abstinent, the mean ELF score was 8.93 on D0, 9.14 on D30 (p = 0.32), and 9.27 on D90 (p = 0.14). In patients who resumed alcohol, mean ELF score was 9.7 on D0, 10.05 on D30 (p = 0.09), and 9.71 on D90 (p = 0.12). ELF score was comparable over the first months after withdrawal, although there was a slight increase in the first week (mean ELF score increased from 9.24 on D0 to 9.74 on D7, p < 0.001). Mean TE value was 7.9 kPa on D4 and 8.1 kPa on D30 (p = 0.84) in patients who resumed alcohol consumption, and 8.3 and 7.5 kPa (p = 0.03) on D4 and D30, respectively, in abstinent patients. The ELF score is stable during the first months after withdrawal and thus appears to be a useful tool to assess liver fibrosis or cirrhosis in this setting. Nevertheless, because in the first week there is a transient increase in ELF score, caution in interpretation is warranted.
Sections du résumé
BACKGROUND
BACKGROUND
Enhanced liver fibrosis (ELF) score is an accurate, noninvasive test for assessing the severity of liver fibrosis in chronic liver disease, including alcohol-related liver disease. However, whether the ELF score changes during alcohol withdrawal is unknown. This pilot study assessed changes in the ELF score during withdrawal in patients with a history of excessive alcohol intake.
METHODS
METHODS
In this prospective study, ELF was performed on day 0 (D0, at the beginning of hospitalization), at day 7 (D7, on discharge from hospital), and at follow-up visits on days 30 (D30) and 90 (D90). Transient elastography (TE) was also assessed on days 4 (D4) and D30.
RESULTS
RESULTS
The study included 35 patients (71% male) with a mean alcohol intake of 139 g/day. On D30 and D90, 8 and 13 patients had resumed alcohol consumption (mean intake of 90 and 80 g/day, respectively). In patients who remained abstinent, the mean ELF score was 8.93 on D0, 9.14 on D30 (p = 0.32), and 9.27 on D90 (p = 0.14). In patients who resumed alcohol, mean ELF score was 9.7 on D0, 10.05 on D30 (p = 0.09), and 9.71 on D90 (p = 0.12). ELF score was comparable over the first months after withdrawal, although there was a slight increase in the first week (mean ELF score increased from 9.24 on D0 to 9.74 on D7, p < 0.001). Mean TE value was 7.9 kPa on D4 and 8.1 kPa on D30 (p = 0.84) in patients who resumed alcohol consumption, and 8.3 and 7.5 kPa (p = 0.03) on D4 and D30, respectively, in abstinent patients.
CONCLUSION
CONCLUSIONS
The ELF score is stable during the first months after withdrawal and thus appears to be a useful tool to assess liver fibrosis or cirrhosis in this setting. Nevertheless, because in the first week there is a transient increase in ELF score, caution in interpretation is warranted.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Institut National de la Santé et de la Recherche Médicale
Organisme : French Government (National Research Agency, ANR)
ID : ANR-19-CE14-0044-01
Organisme : French Government (National Research Agency, ANR)
ID : ANR-21-CE14-0015-03
Organisme : French Government (National Research Agency, ANR)
ID : ANR-22-CE14-0027-01
Organisme : French Government (National Research Agency, ANR)
ID : ANR-23-CE14-0048-03
Organisme : French Government (National Research Agency, ANR)
ID : ANR-11-LABX-0028-01
Organisme : French Government (National Research Agency, ANR)
ID : ANR-15-IDEX-01
Informations de copyright
© 2024 The Authors. Alcohol, Clinical and Experimental Research published by Wiley Periodicals LLC on behalf of Research Society on Alcohol.
Références
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders, 5th edition.
An International Group. (1981) Alcoholic liver disease: morphological manifestations. The Lancet, 317(8222), 707–711. Available from: https://doi.org/10.1016/S0140‐6736(81)91984‐X
Bardou‐Jacquet, E., Legros, L., Soro, D., Latournerie, M., Guillygomarc'h, A., Le Lan, C. et al. (2013) Effect of alcohol consumption on liver stiffness measured by transient elastography. World Journal of Gastroenterology, 19, 516–522. Available from: https://doi.org/10.3748/wjg.v19.i4.516
Connoley, D., Patel, P.J., Hogan, B., Tanwar, S., Rhodes, F., Parkes, J. et al. (2021) The enhanced liver fibrosis test maintains its diagnostic and prognostic performance in alcohol‐related liver disease: a cohort study. BMC Gastroenterology, 21, 268. Available from: https://doi.org/10.1186/s12876‐021‐01795‐5
European Association for the Study of the Liver. (2018) EASL clinical practice guidelines: management of alcohol‐related liver disease. Journal of Hepatology, 69, 154–181. Available from: https://doi.org/10.1016/j.jhep.2018.03.018
Filingeri, V., Francioso, S., Sforza, D., Santopaolo, F., Oddi, F. M. & Tisone, G. (2016). A retrospective analysis of 1.011 percutaneous liver biopsies performed in patients with liver transplantation or liver disease: ultrasonography can reduce complications? European review for medical and pharmacological sciences, 20(17), 3609–3617.
Gelsi, E., Dainese, R., Truchi, R., Mariné‐Barjoan, E., Anty, R., Autuori, M. et al. (2011) Effect of detoxification on liver stiffness assessed by Fibroscan® in alcoholic patients. Alcoholism, Clinical and Experimental Research, 35, 566–570. Available from: https://doi.org/10.1111/j.1530‐0277.2010.01374.x
Gianni, E., Forte, P., Galli, V., Razzolini, G., Bardazzi, G. & Annese, V. (2017) Prospective evaluation of liver stiffness using transient elastography in alcoholic patients following abstinence. Alcohol and Alcoholism, 52, 42–47. Available from: https://doi.org/10.1093/alcalc/agw053
Ginès, P., Krag, A., Abraldes, J.G., Solà, E., Fabrellas, N. & Kamath, P.S. (2021) Liver cirrhosis. Lancet, 398, 1359–1376. Available from: https://doi.org/10.1016/S0140‐6736(21)01374‐X
Lackner, C., Spindelboeck, W., Haybaeck, J., Douschan, P., Rainer, F., Terracciano, L. et al. (2017) Histological parameters and alcohol abstinence determine long‐term prognosis in patients with alcoholic liver disease. Journal of Hepatology, 66, 610–618. Available from: https://doi.org/10.1016/j.jhep.2016.11.011
Legros, L., Bardou‐Jacquet, E., Turlin, B., Michalak, S., Hamonic, S., Le Gruyer, A. et al. (2022) Transient elastography accurately screens for compensated advanced chronic liver disease in patients with ongoing or recent alcohol withdrawal. Clinical Gastroenterology and Hepatology, 20, 1542–1552.e6. Available from: https://doi.org/10.1016/j.cgh.2021.02.021
Liao, Y., Gong, J., Zhou, W., Dong, H., Liang, J., Luo, M. et al. (2019) Serum liver fibrosis markers discriminate significant liver inflammation in chronic hepatitis B patients with normal or near‐normal alanine aminotransferase. Journal of Medical Virology, 91, 642–649. Available from: https://doi.org/10.1002/jmv.25364
Lichtinghagen, R., Pietsch, D., Bantel, H., Manns, M.P., Brand, K. & Bahr, M.J. (2013) The enhanced liver fibrosis (ELF) score: normal values, influence factors and proposed cut‐off values. Journal of Hepatology, 59, 236–242. Available from: https://doi.org/10.1016/j.jhep.2013.03.016
Lurie, Y., Webb, M., Cytter‐Kuint, R., Shteingart, S. & Lederkremer, G.Z. (2015) Non‐invasive diagnosis of liver fibrosis and cirrhosis. World Journal of Gastroenterology, 21, 11567–11583. Available from: https://doi.org/10.3748/wjg.v21.i41.11567
Miele, L., Forgione, A., La Torre, G., Vero, V., Cefalo, C., Racco, S. et al. (2009) Serum levels of hyaluronic acid and tissue metalloproteinase inhibitor‐1 combined with age predict the presence of nonalcoholic steatohepatitis in a pilot cohort of subjects with nonalcoholic fatty liver disease. Translational Research, 154, 194–201. Available from: https://doi.org/10.1016/j.trsl.2009.06.007
Mueller, S., Millonig, G., Sarovska, L., Friedrich, S., Reimann, F.M., Pritsch, M. et al. (2010) Increased liver stiffness in alcoholic liver disease: differentiating fibrosis from steatohepatitis. World Journal of Gastroenterology, 16, 966–972. Available from: https://doi.org/10.3748/wjg.v16.i8.966
Nguyen‐Khac, E., Thiele, M., Voican, C., Nahon, P., Moreno, C., Boursier, J. et al. (2018) Non‐invasive diagnosis of liver fibrosis in patients with alcohol‐related liver disease by transient elastography: an individual patient data meta‐analysis. The Lancet Gastroenterology & Hepatology, 3, 614–625. Available from: https://doi.org/10.1016/S2468‐1253(18)30124‐9
Nouchi, T., Worner, T.M., Sato, S. & Lieber, C.S. (1987) Serum procollagen type III N‐terminal peptides and laminin P1 peptide in alcoholic liver disease. Alcoholism, Clinical and Experimental Research, 11, 287–291. Available from: https://doi.org/10.1111/j.1530‐0277.1987.tb01309.x
Ponomarenko, Y., Leo, M.A., Kroll, W. & Lieber, C.S. (2002) Effects of alcohol consumption on eight circulating markers of liver fibrosis. Alcohol and Alcoholism, 37, 252–255. Available from: https://doi.org/10.1093/alcalc/37.3.252
Rhodes, F., Cococcia, S., Panovska‐Griffiths, J., Tanwar, S., Westbrook, R.H., Rodger, A. et al. (2021) Uncovering unsuspected advanced liver fibrosis in patients referred to alcohol nurse specialists using the ELF test. BMC Gastroenterology, 21, 143. Available from: https://doi.org/10.1186/s12876‐021‐01728‐2
Rosenberg, W.M.C., Voelker, M., Thiel, R., Becka, M., Burt, A., Schuppan, D. et al. (2004) Serum markers detect the presence of liver fibrosis: a cohort study. Gastroenterology, 127, 1704–1713. Available from: https://doi.org/10.1053/j.gastro.2004.08.052
Rousselet, M.‐C., Michalak, S., Dupré, F., Croué, A., Bedossa, P., Saint‐André, J.‐P. et al. (2005) Sources of variability in histological scoring of chronic viral hepatitis. Hepatology, 41, 257–264. Available from: https://doi.org/10.1002/hep.20535
Sereny, G., Rapoport, A. & Husdan, H. (1966) The effect of alcohol withdrawal on electrolyte and acid‐base balance. Metabolism, 15, 896–904. Available from: https://doi.org/10.1016/0026‐0495(66)90160‐0
Taivainen, H., Laitinen, K., Tähtelä, R., Kilanmaa, K. & Välimäki, M.J. (1995) Role of plasma vasopressin in changes of water balance accompanying acute alcohol intoxication. Alcoholism, Clinical and Experimental Research, 19, 759–762. Available from: https://doi.org/10.1111/j.1530‐0277.1995.tb01579.x
Thiele, M., Madsen, B.S., Hansen, J.F., Detlefsen, S., Antonsen, S. & Krag, A. (2018) Accuracy of the enhanced liver fibrosis test vs FibroTest, Elastography, and indirect markers in detection of advanced fibrosis in patients with alcoholic liver disease. Gastroenterology, 154, 1369–1379. Available from: https://doi.org/10.1053/j.gastro.2018.01.005
Trabut, J.‐B., Thépot, V., Nalpas, B., Lavielle, B., Cosconea, S., Corouge, M. et al. (2012) Rapid decline of liver stiffness following alcohol withdrawal in heavy drinkers. Alcoholism, Clinical and Experimental Research, 36, 1407–1411. Available from: https://doi.org/10.1111/j.1530‐0277.2012.01737.x